Harm Our Immune Systems?

Angie Szumlinski Health

An article published on MIT Medical asks the question, “is all this social distancing weakening our immune systems?” According to MIT, the answer is NO, that this is NOT the way our immune system works. The idea that individuals who are exposed to a variety of microbes (i.e., germs) in childhood build better immunity is likely to be true! In …

CDC Update – Underlying Medical Conditions – High Risk for COVID

Angie Szumlinski Announcements

“We are learning more about the risk factors for severe COVID-19 outcomes every day. Age is the strongest risk factor for severe COVID-19 outcomes. Approximately 54.1 million people aged 65 years or older reside in the United States; this age group accounts for more than 80% of U.S. COVID-19 related deaths. Residents of long-term care facilities make up less than …

Preventing Delirium During Isolation

Angie Szumlinski Featured, Health

A recent JAMA article discusses how delirium emerged as a well-recognized complication of COVID-19, with particular importance due to its high prevalence and mortality. Unfortunately, early signs of delirium (also referred to as acute brain failure) are often “missed”. During the COVID-19 pandemic, reversible contributors to delirium must be addressed and approaches for delirium prevention and management can be built …

Mix and Match

Angie Szumlinski Featured, Health

In a recent podcast posted on NPR, the practice of mixing different kinds of COVID-19 vaccines was discussed. Typically, if you get a COVID-19 vaccine that requires two doses, you should get two of the same vaccine. Two Pfizer shots, or two Moderna shots, not one and then the other. “In the U.K. at the moment, we’re sort of calling …

The Fat Lady Sings

Angie Szumlinski Studies

In an article published in Forbes magazine, three companies are currently leading the way to develop a vaccine that will be effective against all variants of COVID-19. The goal of this research is to possibly prevent a future pandemic from variants of the COVID-19 virus. The current providers of COVID-19 vaccines (Pfizer, Moderna and J&J) are focusing their attention on …

Will Pandemic End in July?

Angie Szumlinski Featured, Health

Reported in a Medical Press article, a team of infectious disease modelers at Northeastern University has been answering the question “when will the pandemic be over” since January. The group has been developing a set of predictive models to project the future of the outbreak in various scenarios for the U.S. Centers for Disease Control and Prevention as part of …

Corona Virus - Microbiology And Virology Concept - 3d Rendering

Say it Isn’t So!

Angie Szumlinski Studies

In a study published in the Lancet Respiratory Medicine on April 15th, more than 3,000 young, healthy members of the U.S. Marines found that “reinfection by SARS-CoV-2 in healthy young adults is common,” said Stuart Sealfon, MD the Sra B. and Seth M. Glickenhaus Professor of Neurology at the Icahn School of Medicine at Mount Sinai. “Despite a prior COVID-19 …

Booster Shots

Angie Szumlinski News

Executives at Pfizer and BioNTech previously said people will likely need a booster shot or third dose, within 12 months of getting fully vaccinated. They also said it is likely people will need to get additional shots every year. Last month, Andy Slavitt, senior advisor to President Joe Biden’s COVID response team, said the White House is preparing for the …

Antigen Versus PCR

Angie Szumlinski Health, Studies

As we are all aware, the COVID-19 pandemic has hit our communities hard. Despite guidelines on co-horting and testing, and our efforts to protect our residents, nursing homes experienced large outbreaks. In a recent study published in JAMA Network Open, a discussion on whether pre-symptomatic and asymptomatic transmission could be the reason. Long-term separation after recovery kept the non-COVID-19 residents …

Vaccination and Infection

Angie Szumlinski Studies

In a study published in JAMA Network, “regularly screened health care workers who had received 2 doses of the BNT162b2 messenger RNA vaccine were associated with significantly lower incidence rates for both symptomatic and asymptomatic infection. The association between vaccination status and symptomatic SARS-CoV-2 infection is similar to the 95% efficacy reported in the phase 3 randomized clinical trial. Asymptomatic …